Diet Induced Ketosis for Patients With Posttraumatic Stress Disorder (PTSD), a Feasibility Study
Primary Purpose
PTSD, Post Traumatic Stress Disorder
Status
Recruiting
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Ketogenic Diet
Sponsored by
About this trial
This is an interventional treatment trial for PTSD
Eligibility Criteria
Inclusion Criteria:
- Patients 18-65 years
- Diagnosed with posttraumatic stress disorder (PTSD)
- Understand and speak Scandinavian language
Exclusion Criteria:
- Body Mass Index < 18
- Metabolic disorders contraindicating a ketogenic diet
- Dysregulated Diabetes Mellitus
- Medicated for elevated triglycerides
- Pancreas, kidney or liver disorders
Sites / Locations
- Søndre Oslo Distriktspsykiatriske Senter (DPS)Recruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Ketogenic Diet
Arm Description
Ketogenic Diet every day for 4 weeks
Outcomes
Primary Outcome Measures
Recruitment
How many patients can be included in the intervention group (percent out of all eligible patients during the inclusion period)
Completing the intervention
How many patients complete the intervention of four weeks (percent out of all included patients) Completion is defined as adherence to the intervention daily for four weeks.
Maintaining ketosis
Could ketosis (mean b-BHB ≥ 0,5 mmol/L out of three daily measurements) be maintained for the duration of intervention (percent out of intervention days since ketosis first was obtained)
Adverse reactions related to the ketogenic treatment
The occurrence of adverse reactions (percent of days with adverse reactions during intervention)
Secondary Outcome Measures
Assessment of severity of PTSD symptoms
Change in PTSD Checklist for DSM-5 scale (PCL-5). 20 part item, 0-4 likert scale. Minimum value 0, maximum value 80 (Lower score is better)
Measure of Health-Related Quality of Life
Change in RAND 36-Item Health Survey 1.0 (RAND-36) - Scale is converted to numerical values for physical and mental health (each item is scored on a 0 to 100 range, so that the lowest and highest score are 0 and 100, respectively). Items in the same scale are averaged together to create 8 scale scores. A higher score defines a more faborable health state.
Full Information
NCT ID
NCT05415982
First Posted
March 23, 2022
Last Updated
February 26, 2023
Sponsor
Jens Rikardt Andersen
Collaborators
Oslo University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT05415982
Brief Title
Diet Induced Ketosis for Patients With Posttraumatic Stress Disorder (PTSD), a Feasibility Study
Official Title
Diet Induced Ketosis for Patients With Posttraumatic Stress Disorder (PTSD), a Feasibility Study
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 1, 2022 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Jens Rikardt Andersen
Collaborators
Oslo University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Many patients suffering from posttraumatic stress disorder (PTSD) are resistant to established treatment consisting of psychotherapy. Patients often go years with this debilitating disorder without experiencing sufficient improvement. Approximately 1/3 of patients will drop out of treatment because of psychological burden and overactivation. A novel ketogenic diet treatment could amend established treatment, and potentially upregulate the threshold for exciting neurons in dysfunctional brain regions, mediated through various mechanisms. This may reduce PTSD symptoms, and thus enabling patients to respond to psychological treatment without getting overactivated and unable to process trauma. The purpose of this study is to investigate whether it is possible to carry out a ketogenic diet therapy for patients with PTSD for four weeks.
Detailed Description
The study aims to include 10 PTSD patients. If a participant drops out of the study, or if the study is otherwise terminated for a participant, another patient will be recruited until 10 have completed the study. The primary objectives of this feasibility study are to investigate if it is possbile to carry out a ketogenic diet therapy for patients with PTSD for 4 weeks, and systematically gain insight in all challenges relating to these objectives. The participants will follow a ketogenic diet for 4 weeks, and they are asked to self report daily on results from finger pricking blood measurements (glucose and betahydroxybutyrate (BHB)) to establish they are in a ketogenic state and are compliant to diet. Participants will also report food intake and side effects daily to be evaluated by the principal investigator. Participants are further asked to specify and elaborate on which adverse effects or other reasons as to why it is challenging to follow the study diet and/or procedures. The study lacks in power to statistically evaluate if ketosis has any effect on PTSD symptoms, however this secondary objective will be preliminary evaluated.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
PTSD, Post Traumatic Stress Disorder
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Ketogenic Diet
Arm Type
Experimental
Arm Description
Ketogenic Diet every day for 4 weeks
Intervention Type
Other
Intervention Name(s)
Ketogenic Diet
Intervention Description
The intervention is a ketogenic diet based on high-fat ketogenic meals prepared by the study participants, complemented with ketogenic food products from Natural Ketosis and Vitaflo. Exogenous ketones are provided by Audacious Nutrition. The macronutrient composition of the ketogenic diet given approx.: Fat 87 E%, Carbohydrate 3 E%, Protein 10 E%,
Primary Outcome Measure Information:
Title
Recruitment
Description
How many patients can be included in the intervention group (percent out of all eligible patients during the inclusion period)
Time Frame
25 weeks
Title
Completing the intervention
Description
How many patients complete the intervention of four weeks (percent out of all included patients) Completion is defined as adherence to the intervention daily for four weeks.
Time Frame
4 weeks
Title
Maintaining ketosis
Description
Could ketosis (mean b-BHB ≥ 0,5 mmol/L out of three daily measurements) be maintained for the duration of intervention (percent out of intervention days since ketosis first was obtained)
Time Frame
4 weeks
Title
Adverse reactions related to the ketogenic treatment
Description
The occurrence of adverse reactions (percent of days with adverse reactions during intervention)
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
Assessment of severity of PTSD symptoms
Description
Change in PTSD Checklist for DSM-5 scale (PCL-5). 20 part item, 0-4 likert scale. Minimum value 0, maximum value 80 (Lower score is better)
Time Frame
4 weeks
Title
Measure of Health-Related Quality of Life
Description
Change in RAND 36-Item Health Survey 1.0 (RAND-36) - Scale is converted to numerical values for physical and mental health (each item is scored on a 0 to 100 range, so that the lowest and highest score are 0 and 100, respectively). Items in the same scale are averaged together to create 8 scale scores. A higher score defines a more faborable health state.
Time Frame
4 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients 18-65 years
Diagnosed with posttraumatic stress disorder (PTSD)
Understand and speak Scandinavian language
Exclusion Criteria:
Body Mass Index < 18
Metabolic disorders contraindicating a ketogenic diet
Dysregulated Diabetes Mellitus
Medicated for elevated triglycerides
Pancreas, kidney or liver disorders
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tobias Furuholmen-Jenssen, Student
Phone
+47 95444973
Email
zxs521@alumni.ku.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Jens R Andersen, MD, MPA
Phone
+45 23346654
Email
jra@nexs.ku.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tobias Furuholmen-Jenssen, Student
Organizational Affiliation
University of Copenhagen
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jens R Andersen, MD, MPA
Organizational Affiliation
University of Copenhagen
Official's Role
Study Director
Facility Information:
Facility Name
Søndre Oslo Distriktspsykiatriske Senter (DPS)
City
Oslo
ZIP/Postal Code
1281
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tobias Furuholmen-Jenssen, Student
Phone
+47 95444973
Email
zxs521@alumni.ku.dk
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Diet Induced Ketosis for Patients With Posttraumatic Stress Disorder (PTSD), a Feasibility Study
We'll reach out to this number within 24 hrs